The influence of population stratification on genetic markers associated with type 1 diabetes

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorGOMES, Karla Fabiana Brasil
dc.contributor.authorSANTOS, Aritania Sousa
dc.contributor.authorSEMZEZEM, Cintia
dc.contributor.authorCORREIA, Marcia Regina
dc.contributor.authorBRITO, Luciano Abreu
dc.contributor.authorRUIZ, Marcelo Ortega
dc.contributor.authorFUKUI, Rosa Tsuneshiro
dc.contributor.authorMATIOLI, Sergio Russo
dc.contributor.authorPASSOS-BUENO, Maria Rita
dc.contributor.authorSILVA, Maria Elizabeth Rossi da
dc.date.accessioned2017-04-07T15:13:37Z
dc.date.available2017-04-07T15:13:37Z
dc.date.issued2017
dc.description.abstractEthnic admixtures may interfere with the definition of type 1 diabetes (T1D) risk determinants. The role of HLA, PTPN22, INS-VNTR, and CTLA4 in T1D predisposition was analyzed in Brazilian T1D patients (n = 915), with 81.7% self-reporting as white and 789 controls (65.6% white). The results were corrected for population stratification by genotyping 93 ancestry informative markers (AIMs) (BeadXpress platform). Ancestry composition and structural association were characterized using Structure 2.3 and STRAT. Ethnic diversity resulted in T1D determinants that were partially discordant from those reported in Caucasians and Africans. The greatest contributor to T1D was the HLA-DR3/DR4 genotype (OR = 16.5) in 23.9% of the patients, followed by -DR3/DR3 (OR = 8.9) in 8.7%, -DR4/DR4 (OR = 4.7) in 6.0% and -DR3/DR9 (OR = 4.9) in 2.6%. Correction by ancestry also confirmed that the DRB1*09DQB1*0202 haplotype conferred susceptibility, whereas the DRB1*07-DQB1*0202 and DRB1*11DQB1*0602 haplotypes were protective, which is similar to reports in African-American patients. By contrast, the DRB1*07-DQB1*0201 haplotype was protective in our population and in Europeans, despite conferring susceptibility to Africans. The DRB1*10-DQB1*0501 haplotype was only protective in the Brazilian population. Predisposition to T1D conferred by PTPN22 and INS-VNTR and protection against T1D conferred by the DRB1*16 allele were confirmed. Correcting for population structure is important to clarify the particular genetic variants that confer susceptibility/protection for T1D in populations with ethnic admixtures.
dc.description.indexMEDLINE
dc.identifier.citationSCIENTIFIC REPORTS, v.7, article ID 43513, 10p, 2017
dc.identifier.doi10.1038/srep43513
dc.identifier.issn2045-2322
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/18994
dc.language.isoeng
dc.publisherNATURE PUBLISHING GROUP
dc.relation.ispartofScientific Reports
dc.rightsopenAccess
dc.rights.holderCopyright NATURE PUBLISHING GROUP
dc.subject.othersusceptibility
dc.subject.otherhaplotypes
dc.subject.wosMultidisciplinary Sciences
dc.titleThe influence of population stratification on genetic markers associated with type 1 diabetes
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalBRITO, Luciano Abreu:Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Rua Matao 277, BR-05422970 Sao Paulo, SP, Brazil
hcfmusp.author.externalRUIZ, Marcelo Ortega:Immunol Lab, Rua Claudio Manoel Costa,270 Marilia Sao Paulo, Sao Paulo, SP, Brazil
hcfmusp.author.externalMATIOLI, Sergio Russo:Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Rua Matao 277, BR-05422970 Sao Paulo, SP, Brazil
hcfmusp.author.externalPASSOS-BUENO, Maria Rita:Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Rua Matao 277, BR-05422970 Sao Paulo, SP, Brazil
hcfmusp.citation.scopus23
hcfmusp.contributor.author-fmusphcKARLA FABIANA BRASIL GOMES
hcfmusp.contributor.author-fmusphcARITANIA SOUSA SANTOS
hcfmusp.contributor.author-fmusphcCINTIA SEMZEZEM
hcfmusp.contributor.author-fmusphcMARCIA REGINA SOARES CORREIA
hcfmusp.contributor.author-fmusphcROSA TSUNECHIRO FUKUI
hcfmusp.contributor.author-fmusphcMARIA ELIZABETH ROSSI DA SILVA
hcfmusp.description.articlenumber43513
hcfmusp.description.volume7
hcfmusp.origemWOS
hcfmusp.origem.pubmed28262800
hcfmusp.origem.scopus2-s2.0-85014760454
hcfmusp.origem.wosWOS:000395428700001
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAmerican Diabetes Association, 2015, DIABETES CARE S1, V38
hcfmusp.relation.referenceBennett ST, 1997, NAT GENET, V17, P350, DOI 10.1038/ng1197-350
hcfmusp.relation.referenceBottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323
hcfmusp.relation.referenceBussab W. O., 1987, ESTATISTICA BASICA
hcfmusp.relation.referenceMattana TCC, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/694948
hcfmusp.relation.referenceConover WJ, 1980, PRACTICAL NONPARAMET
hcfmusp.relation.referenceDonner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143
hcfmusp.relation.referenceEisenbarth G. S., TYPE 1 DIABETES CELL
hcfmusp.relation.referenceErlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331
hcfmusp.relation.referenceFalush D, 2003, GENETICS, V164, P1567
hcfmusp.relation.referenceGomes MB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-67
hcfmusp.relation.referenceHauache OM, 2005, DIS MARKERS, V21, P139
hcfmusp.relation.referenceKarvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516
hcfmusp.relation.referenceMainardi-Novo DTO, 2013, CLIN EXP IMMUNOL, V172, P16, DOI 10.1111/cei.12030
hcfmusp.relation.referenceMiller SA, 1998, NUCLEIC ACIDS RES, V16, P1215
hcfmusp.relation.referenceNassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39
hcfmusp.relation.referenceNeter J., 1990, APPL LINEAR STAT MOD
hcfmusp.relation.referenceNoble JA, 2013, DIABETES, V62, P3292, DOI 10.2337/db13-0094
hcfmusp.relation.referencePena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
hcfmusp.relation.referencePritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959
hcfmusp.relation.referenceSilva Maria Elizabeth Rossi da, 2008, Arq Bras Endocrinol Metabol, V52, P166
hcfmusp.relation.referenceSteck A. K., 2004, ADV EXP MED BIOL, V552, P170
hcfmusp.relation.referenceThomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x
hcfmusp.relation.referenceUndlien D. E., 1999, DIABETOLOGIA
hcfmusp.relation.referenceWiner BJ., 1971, STAT PRINCIPLES EXPT
hcfmusp.relation.referenceZhang Q., 2012, DIABETES RES CLIN PR, V97, P446
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication70df978d-ce43-4c5f-9390-7a09cf112c81
relation.isAuthorOfPublication4fa854ab-5c63-4d62-9734-5a3f9bb165d9
relation.isAuthorOfPublication9a7fc3e1-98ab-4302-9afa-1ee4e31fce78
relation.isAuthorOfPublication8ab67ab9-a4e2-4bde-8eea-be1f1b43afde
relation.isAuthorOfPublication6b0dd28e-3ed8-484a-9abc-89af511f78dd
relation.isAuthorOfPublication597d1c65-b997-402c-90e3-98b5905a1ca4
relation.isAuthorOfPublication.latestForDiscovery70df978d-ce43-4c5f-9390-7a09cf112c81
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_GOMES_The_influence_of_population_stratification_on_genetic_markers_2017.PDF
Tamanho:
497.63 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)